| Mr Timothy Dale Ashley Jr, MD | |
|
2900 E 29th St, Suite 100, Bryan, TX 77802-2622 | |
| (979) 436-0485 | |
| Not Available |
| Full Name | Mr Timothy Dale Ashley Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 2900 E 29th St, Bryan, Texas |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043570617 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 193400000X (Texas) | Secondary |
| 207Q00000X | Family Medicine | 34205 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alacare Home Health & Hospice | Birmingham, AL | Hospice |
| North Alabama Medical Center | Florence, AL | Hospital |
| Mitchell-hollingsworth Nursing & Rehabilitation | Florence, AL | Nursing home |
| Entity Name | Ecm Health Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346588852 PECOS PAC ID: 9436395225 Enrollment ID: O20130424000304 |
News Archive
A team of scientists from the United Kingdom has designed an experimental medicine trial to evaluate the safety/tolerability, and efficacy profiles of a panel of candidate repurposed therapies in coronavirus disease 2019 (COVID-19) patients. A detailed outline of the trial is currently available on the medRxiv* preprint server.
Curiosity is a driving factor in why most kids start smoking, and the same is true for kids with asthma.
Ahead of World Tuberculosis (TB) Day on March 24, three non-governmental organizations (NGOs) released a joint statement warning that "[a] $1.7 billion funding shortfall to fight [TB] over the next five years means 3.4 million patients will go untreated and gains made against the disease will be reversed," Reuters reports.
The plan's key health components include an overhaul of the Medicare physician payment system and a repeal of the health law's long-term care insurance program. Kaiser Health News provides the executive summary of the plan.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 7 days ago
| Entity Name | Dr Ty Ashley Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972970358 PECOS PAC ID: 6406165190 Enrollment ID: O20151020001990 |
News Archive
A team of scientists from the United Kingdom has designed an experimental medicine trial to evaluate the safety/tolerability, and efficacy profiles of a panel of candidate repurposed therapies in coronavirus disease 2019 (COVID-19) patients. A detailed outline of the trial is currently available on the medRxiv* preprint server.
Curiosity is a driving factor in why most kids start smoking, and the same is true for kids with asthma.
Ahead of World Tuberculosis (TB) Day on March 24, three non-governmental organizations (NGOs) released a joint statement warning that "[a] $1.7 billion funding shortfall to fight [TB] over the next five years means 3.4 million patients will go untreated and gains made against the disease will be reversed," Reuters reports.
The plan's key health components include an overhaul of the Medicare physician payment system and a repeal of the health law's long-term care insurance program. Kaiser Health News provides the executive summary of the plan.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Timothy Dale Ashley Jr, MD 727 Cox Creek Parkway, Florence, AL 35630-1001 Ph: (256) 764-9613 | Mr Timothy Dale Ashley Jr, MD 2900 E 29th St, Suite 100, Bryan, TX 77802-2622 Ph: (979) 436-0485 |
News Archive
A team of scientists from the United Kingdom has designed an experimental medicine trial to evaluate the safety/tolerability, and efficacy profiles of a panel of candidate repurposed therapies in coronavirus disease 2019 (COVID-19) patients. A detailed outline of the trial is currently available on the medRxiv* preprint server.
Curiosity is a driving factor in why most kids start smoking, and the same is true for kids with asthma.
Ahead of World Tuberculosis (TB) Day on March 24, three non-governmental organizations (NGOs) released a joint statement warning that "[a] $1.7 billion funding shortfall to fight [TB] over the next five years means 3.4 million patients will go untreated and gains made against the disease will be reversed," Reuters reports.
The plan's key health components include an overhaul of the Medicare physician payment system and a repeal of the health law's long-term care insurance program. Kaiser Health News provides the executive summary of the plan.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 7 days ago
Clayton Thomas Kruger, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2900 E 29th St, Bryan, TX 77802 Phone: 979-776-8400 | |
Dr. Robert B Hash, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1301 Memorial Dr, Bryan, TX 77802 Phone: 979-776-8440 | |
Ricardo Garcia Jr., D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3121 University Dr E Ste 100, Bryan, TX 77802 Phone: 979-776-0169 Fax: 979-776-1372 | |
Dr. Puifun Lila Pappas, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2410 Boonville Rd, Bryan, TX 77808 Phone: 979-690-4808 Fax: 979-690-4809 | |
Nikki L Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 E 29th St Ste 100, Bryan, TX 77802 Phone: 979-436-0485 | |
David Reyes Damian Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2210 E 29th St, Bryan, TX 77802 Phone: 979-821-6300 Fax: 979-823-4543 |